TRAjectories and CLinical ExpeRiences of ICD Therapy Study
NCT: NCT05116176 · ENROLLING_BY_INVITATION
Brief Summary
This is a prospective cohort study of older patients receiving implantable cardioverter-defibrillators. The purpose of the TRACER-ICD study is to conduct a prospective cohort investigation with the goal of 500 patients age \>65 receiving new primary prevention implantable cardioverter-defibrillators (ICDs). Patients will be followed quarterly for 18 months with interviews, electronic record review, and remote monitoring to characterize clinical and functional trajectories following device implantation, with permission for extended electronic follow-up for up to 10 years (Aim 1). This cohort will support validation and refinement of an established model for predicting personalized outcome profiles for ICD therapies and death (Aim 2). Lastly, we will combine electronic record review with semi-structured interviews with patients and physicians to evaluate physician and patient experiences with a prototype individualized shared decision-making (SDM) tool (Aim 3).
Frequently Asked Questions
What is TRAjectories and CLinical ExpeRiences of ICD Therapy Study?
TRAjectories and CLinical ExpeRiences of ICD Therapy Study is a clinical trial registered under NCT05116176. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT05116176?
The current status of NCT05116176 (TRAjectories and CLinical ExpeRiences of ICD Therapy Study) is: ENROLLING_BY_INVITATION.
When did TRAjectories and CLinical ExpeRiences of ICD Therapy Study start?
TRAjectories and CLinical ExpeRiences of ICD Therapy Study started on 2021-12-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.